Our current results indicated that DUXAP8 and DUXAP9 may act as two key oncogenes in renal cell carcinoma through upregulation of COL1A1 and COL1A2 by competitively binding miR-29c-3p. This evidence concerns the gene DUXAP9 and renal cell carcinoma.